Chinese fund raises Eu Yan Sang stake further
This has spurred speculation about its intentions, even as a consortium has unveiled its privatisation plan
Singapore
A PROMINENT Chinese fund run by billionaire Chinese financier Lei Zhang and backed by Yale University's endowment and Stanford University has upped its substantial stake in traditional Chinese medicine retailer Eu Yan Sang International and spurred talk about its intentions, even as a consortium's privatisation bid for the group unfolds.
Hillhouse Capital Management picked up 21,000 shares in Eu Yan Sang at S$0.615 apiece on Monday, Eu Yan Sang said in a Singapore Exchange (SGX) filing on Tuesday morning. This move took its stake to about 23.49 million shares, or 5.238 per cent of the mainboard-listed group.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
UBS weighs synthetic risk transfer amid capital boost proposals
Oil settles higher on supply concerns in the Mid-East, economic woes subdue gains
S-Reits falter as investors weigh possibility of zero rate cuts in 2024
CapitaLand Investment posts total revenue of S$650 million for Q1
Europe: Stoxx 600 logs best day in three months as banks shine
US: Stocks rally after strong tech results